Challenge
- A partner was developing a Fab fragment to quickly neutralize a therapeutic substrate
- Their E. coli platform generated low Fab titer and meaningful supply was needed for clinical development
- A cost-effective process required titers >2 g/L

SCREENING WORKFLOW
- 800 unique expression strains screened at 96-well scale
- Down-selected strains assessed at 2L scale for Fab titer under multiple induction conditions (pH, temp; induction OD, time, and inducer concentration)
- Fab enriched from selected fermentation pastes via affinity chromatography
- Enriched Fab quality assessed for intact mass
- >4 g/L of active Fab produced


